Oncology Precision Medicine Recorded Session

The Advocate Aurora Health Oncology Precision Medicine Conference will review the use of molecular testing in molecular tumor boards at Advocate Aurora as well as other health systems. Speakers will discuss OPM from the standpoint of pathology, (tele) genetic counseling and implementation in clinical trials.

If you attended any the live session of Oncology Precision Medicine, you will not be able to claim credit again.  You can, however, still watch the content.

Target Audience

This course is intended for Medical Oncologists, Cancer Surgeons, Pathologists, Genetic Counselors, All Medical Staff

Learning Objectives

At the end of this session, learners should be able to:

  1. Understand the multi-disciplinary nature of oncology precision medicine (OPM)
  2. Recognize the difficulties including pathology tissue, biomarker validation, and molecular ambiguity detection from testing results
  3. Appreciate the central importance of genetic counselors in the OPM process 
  4. Review examples of OPM clinical trials and real-world data generation to generate progress and value in oncology
Course summary
Available credit: 
  • 3.75 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 3.75 Attendance
    Attendance Credit
    • 3.75 Approved AMA PRA Category 1 Credit™
  • 3.75 ABIM MOC Part II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Course opens: 
04/21/2020
Course expires: 
12/31/2022
Cost:
$0.00
Part of: 
Oncology Recorded Sessions
Rating: 
0

Faculty

Michael A. Thompson, MD, PhD, FASCO  Medical Co-Director, Oncology Precision Medicine Program, Advocate Aurora Health 
Mary Walters, PharmD, BCOP  Co-Director, Oncology Precision Medicine Program, Advocate Aurora Health 
James Weese, MD, FACS  Vice President of Aurora Cancer Care, Advocate Aurora Health 
MJ Luser, Research Coordinator, Aurora Cancer Care, Advocate Aurora Health 
Michael P. Mullane, MD  Medical Director, Hereditary Cancer Prevention and Management Center, Advocate Aurora Health
Antony Ruggeri, MD  Medical Oncologist, Aurora Cancer Care, Advocate Aurora Health 
Kristen Hanson, Genetic Counselor Sr, Genomic Medicine, Hereditary Cancer Prevention and Management Center, Advocate Aurora Health 
Alicia M Hunt, MD  Anatomic & Clinical Pathology,  Advocate Aurora Health
Dan Hayes, MD, FACP, FASCO  Clinical Director of the Breast Oncology Program, University of Michigan
Frank Zuehl, MD  Anatomic & Clinical Pathology,  Advocate Aurora Health
Milan Radovich, PhD  Co-Director of the IU Health Precision Genomics Program, IU Health Vice- President for Oncology Genomics
Peter O’Dwyer, MD  Co-chair ECOG-ACRIN
Edward S. Kim, MD, MBA  Physician-In-Chief, City of Hope OC; Immediate Past Chair, ASCO TAPUR Steering Committee
Thomas D. Brown, MD  Chief Medical Officer, Syapse

 

Disclosure

The following faculty speakers and/or planning committee members have disclosed the following:

Faculty NameName of Commercial InterestNature of Relationship
Michael Thompson, MDAdaptive; BMS (Celgene); GRAIL/Illumina; Syapse; TakedaAdvisory Board
 ElsevierCo-chair, clinical pathways
 UpToDatePeer Reviewer
   
Thomas Brown, MDSygnomicsAdvisor
 GenomiCareScientific Advisory Board
 NovartisSpeakers Bureau
   
Kristen HansonInvitae CorporationAdvisory Board Member
   
Daniel Hayes, MDInbiomotionStock Options
 Cepheid; Freenome, Inc.; Artiman Ventures (Cellworks); Agendia, Inc.; Lexent; Epic Sciences, Inc.; Salutogenic Innovations, LLC; L-Nutra; BioVeca; OncoCyteConsultant
 Merrimack Pharmaceuticals, Inc.; Eli Lilly Company; Menarini/Silicon BioSystems; Veridex (Johnson & Johnson); Puma Biotechnology, Inc.; Pfizer; Astra ZenecaSponsored Clinical Research
 Janssen R&D, LLC (Johnson & Johnson)Royalties
 Immunicon Corporation; University of MichiganInventor
 UpToDateEditor
 MedPageEducation Development
 CancerExpertNowExpert Panel Member
   
Edward Kim, MDAZ; Boerhinger Ingelheim; Roche/GenentechConsulting
 TakedaScientific Advisory Board
   
Peter O'Dwyer, MDPfizer; Genentech; BMS; AZ; GSK; Five Prime; FortySeven; Merck; Syndax; BBI; Novartis; Celgene; Incyte; Lilly/Imclone; array; h3biomedicine; Taiho; Minneamrat; pharmacyclics/abbvie; MiratiResearch Support
 Genentech; ArrayConsulting
 Bayer; LillyExpert Testimony
   
Milan Radovich, PhDLifeOmicScientific Advisor
 Lilly; Boston BiomedicalPrincipal Investigator
 Tyme Technologies; Immunomedics; MacrogenicsInvestor
   

The other planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. Conflict of interest have been identified and mitigated prior to the activity.

Accreditation Statement
Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Advocate Aurora Health designates this enduring material for a maximum of 3.75 AMA PRA Category 1 credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


 

Available Credit

  • 3.75 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 3.75 Attendance
    Attendance Credit
    • 3.75 Approved AMA PRA Category 1 Credit™
  • 3.75 ABIM MOC Part II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Price

Cost:
$0.00
Please login or register to take this course.

If you attended any the live session of Oncology Precision Medicine, you will not be able to claim credit again.  You can, however, still watch the content.

Contact the Advocate Aurora Health CME Office at cme@aah.org if you have any questions or need assistance.

Main Sessions